Ultragenyx Pharmaceutical Inc.
NASDAQUltragenyx Pharmaceutical heads into the back half of June with a sharp disconnect between its 9% weekly rally and an options market suddenly pricing in the most defensive posture it has struck in nearly a year. The clearest signal this week is in options. The put/call ratio jumped to 0.997 on Tuesday — almost exactly even money between puts and calls — which sounds unremarkable…
Snapshot as of 22 Jun 2026
Ultragenyx Pharmaceutical heads into the back half of June with a sharp disconnect between its 9% weekly rally and an options market suddenly pricing in the most defensive posture it has struck in nearly a year. The…
Ultragenyx Pharmaceutical heads into the post-earnings week with short sellers adding positions and analysts pulling in opposite directions — a split that reflects the market's unresolved read on whether the Q1 revenue…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for RARE — free to start on ORTEX.
Sign up for free →Open RARE on ORTEX